Expression of bcl-2 by human bone marrow mast cells and its overexpression in mast cell leukemia

American Journal of Hematology

Volumn 60, Issue 3, 1999, Pages 191-195

  Cerveró, Carlos ^a   Escribano, Luis ^a   San Miguel, Jesús F ^b   Díaz Agustín, Beatriz ^a   Bravo, Pilar ^a   Villarrubia, Jesús ^a   García Sanz, Ramón ^b   Velasco, José L ^a   Herrera, Pilar ^a   Vargas, Mario ^b   Gonzalez, Marcos ^b   Navarro, José L ^a   Orfao, Alberto ^b  

^a HOSPITAL RAMÓN Y CAJAL   (Spain)

^b HOSPITAL UNIVERSITARIO DE SALAMANCA   (Spain)

Author keywords

Bcl 2; Flow cytometry; Immunophenotype; Mast cells; Systemic mast cell disease

Indexed keywords

DNA; PROTEIN BCL 2;

ARTICLE; BONE MARROW CELL; CLINICAL ARTICLE; CONTROLLED STUDY; FLOW CYTOMETRY; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; LEUKEMIA; MAST CELL; MAST CELL LEUKEMIA; MASTOCYTOSIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

ADULT; APOPTOSIS; BONE MARROW CELLS; FLOW CYTOMETRY; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LEUKEMIA, MAST-CELL; MAST CELLS; PROTO-ONCOGENE PROTEINS C-BCL-2; TUMOR MARKERS, BIOLOGICAL;

EID: 0033020452     PISSN: 03618609     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-8652(199903)60:3<191::AID-AJH4>3.0.CO;2-Y     Document Type: Article

References (37)

1. Williams GT. Programmed cell death: apoptosis and oncogenesis. Cell 1991;65:1097-1098.
2. Vaux DL, Cory S, Adams JM. Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells. Nature 1988;335:440-442.
3. Hockenbery D, Nunez G, Milliman C, Schreiber RD, Korsmeyer SJ. Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature 1990;348:334-336.
4. Nunez G, London L, Hockenbery D, Alexander M, McKearn JP, Korsmeyer SJ. Deregulated Bcl-2 gene expression selectively prolongs survival of growth factor-deprived hemopoietic cell lines. J Immunol 1990;144:3602-3610.
5. Fanidi A, Harrington EA, Evan GI. Cooperative interaction between c-myc and bcl-2 proto-oncogenes. Nature 1992;359:554-556.
6. Bissonnette RP, Echeverri F, Mahboubi A, Green DR. Apoptotic cell death induced by c-myc is inhibited by bcl-2. Nature 1992;359:552-554.
7. Garcia I, Martinou I, Tsujimoto Y, Martinou JC. Prevention of programmed cell death of sympathetic neurons by the bcl-2 protooncogene. Science 1992;258:302-304.
8. Lithgow T, van Driel R, Bertram JF, Strasser A. The protein product of the oncogene bcl-2 is a component of the nuclear envelope, the endoplasmic reticulum, and the outer mitochondrial membrane. Cell Growth Differ 1994;5:411-417.
9. Tsujimoto Y, Cossman J, Jaffe E, Croce CM. Involvement of the bcl-2 gene in human follicular lymphoma. Science 1985;228:1440-1443.
10. Tsujimoto Y, Croce CM. Analysis of the structure, transcripts, and protein products of bcl-2, the gene involved in human follicular lymphoma. Proc Natl Acad Sci USA 1986;83:5214-5218.
11. Cleary ML, Smith SD, Sklar J. Cloning and structural analysis of cDNAs for bcl-2 and a hybrid bcl-2/immunoglobulin transcript resulting from the t(14:18) translocation. Cell 1986;47:19-28.
12. Adachi M, Tefferi A, Greipp PR, Kipps TJ, Tsujimoto Y. Preferential linkage of bcl-2 to immunoglobulin light chain gene in chronic lymphocytic leukemia. J Exp Med 1990;171:559-564.
13. Raghoebier S, van Krieken JH, Kluin Nelemans JC, Gillis A, van Ommen GJ, Ginsberg AM, Raffeld M, Kluin PM. Oncogene rearrangements in chronic B-cell leukemia. Blood 1991;77:1560-1564.
14. Arock M, Zuany-Amorim C, Singer M, Benhamou M, Pretolani M. Interleukin-10 inhibits cytokine generation from mast cells. Eur J Immunol 1996;26:166-170.
15. Campana D, Coustan Smith E, Manabe A, Buschle M, Raimondi SC, Behm FG, Ashmun R, Arico M, Biondi A, Pui CH. Prolonged survival of B-lineage acute lymphoblastic leukemia cells is accompanied by overexpression of bcl-2 protein. Blood 1993;81:1025-1031.
16. Ladanyi M, Wang S, Niesvizky R, Feiner H, Michaeli J. Protooncogene analysis in multiple myeloma. Am J Pathol 1992;141:949-953.
17. Yoshida Y, Anzai N, Kawahata H. Apoptosis in normal and neoplastic hematopoiesis. Crit Rev Oncol Hematol 1996;24:185-211.
18. Hockenbery DM, Zulter M, Hickey W, Nahm M, Korsmeyer SJ. Bcl-2 protein is topographically restricted in tissues characterised by apoptotic cell death. Proc Natl Acad Sci USA 1991;88:6961-6965.
19. Kitamura Y, Shimada M, Hatanaka K, Miyano Y. Development of mast cells from grafted bone marrow cells in irradiated mice. Nature 1977;268:442-443.
20. Kitamura Y, Go S, Hatanaka K. Decrease of mast cells in W/Wv mice and their increase by bone marrow transplantation. Blood 1978;52: 447-452.
21. Kitamura Y, Hatanaka K, Murakami M, Shibata H, Presence of mast cells precursors in peripheral blood of mice demonstrated by parabiosis. Blood 1979;53:1085-1088.
22. Galli SJ. New insights into "the riddle of the mast cells": Microenvironmental regulation of mast cell development and phenotypic heterogeneity. Lab Invest 1990;62:5-33.
23. Denburg JA, Richardson M, Telizyn S, Bienenstock J. Basophil/mast cell precursors in human peripheral blood. Blood 1983;61:775-780.
24. + bone marrow progenitor cells. J Immunol 1991;146:1410-1415.
25. Ashman RI, Jarboc DL, Conrad DH, Huff TF. The mast cell-committed progenitor: in vitro generation of committed progenitors from bone marrow. J Immunol 1991;146:211-216.
26. Rodewald HR, Dessing M, Dvorak AM, Galli SJ. Identification of a committed precursor for the mast cell lineage. Science 1996;271:818-822.
27. Escribano L, Orfao A, Villarrubia J, Cerveró C, Velasco JL, Martin F, San Miguel JF, Navarro JL. Expression of lymphoid-associated antigens in mast cells: report of a case of systemic mast cell disease. Br J Haematol 1995;91:941-943.
28. Escribano L, Orfao A, Villarrubia J. Martín F, Madruga JI, Cuevas M, Velasco JL, Rios A, San Miguel JF. Sequential immunophenolypic analysis of mast cells in a case of systemic mast cell disease evolving to a mast cell leukemia. Cytometry 1997;30:98-102.
29. Kettelhut BV, Metcalfe DD. Pediatric mastocytosis. J Invest Dermatol 1991;96;15S-18S.
30. Metcalfe DD. Clinical advances in mastocytosis: an interdisciplinary roundtable discussion. J Invest Dermatol 1991;96:suppl:1S-65S.
31. Orfao A, Escribano L, Villarrubia J, Velasco JL, Cerveró C, Ciudad J, Navarro JL, San Miguel JF. Flow cytometric analysis of mast cells from normal and pathological human bone marrow samples. Identification and enumeration. Am J Pathol 1996;149:1493-1499.
32. García-Sanz R, Vargas M, González M, Chillón MC, Balanzategui A, Flores T, Hernández J, Caballero MD, San Miguel JF. Detection of single and associated lesions of the bel-1, bcl-2, bcl-6, c-myc, p53. and p16 genes in B-cell Non-Hodgkin's lymphomas: value of molecular analysis for a better assignment of the histologic subtype. Haematologica 1998;83:209-216.
33. van Dongen JJ, Wolvers Tettero IL. Analysis of immunoglobulin and T cell receptor genes. Part I: basic and technical aspects. Clin Chim Acta 1991;198:1-91.
34. Mekori YA, Oh CK, Metcalfe DD. IL-3-dependent murine mast cells undergo apoptosis on removal of IL-3: Prevention of apoptosis by c-kit ligand. J Immunol 1993;151:3775-3784.
35. Yee NS, Pack I, Besmer P. Role of kit-ligand in proliferation and suppression of apoptosis in mast cells: basis for radiosensitivity of white spotting and Steel mutant mice. J Exp Med 1994;179:1777-1787.
36. Födinger M, Fritsch G, Winkler K, Emminger W, Mitterbauer G, Gadner H, Valent P, Mannhalter C. Origin of human mast cells: development from transplanted hematopoietic stem cells after allogeneic bone marrow transplantation. Blood 1994;84:2954-2959.
37. Kluin-Nelemans HC, Jansen JH, Breukelman H, Wolthers BG, Kluin PM, Kroon HM, Willemze R. Response to interferon ALFA-2b in a patient with systemic mastocytosis. N Engl J Med 1992;326:619-623.